Literature DB >> 35167084

Characterization of Amyloidogenic Peptide Aggregability in Helical Subspace.

Shayon Bhattacharya1, Liang Xu1, Damien Thompson2.   

Abstract

Prototypical amyloidogenic peptides amyloid-β (Aβ) and α-synuclein (αS) can undergo helix-helix associations via partially folded helical conformers, which may influence pathological progression to Alzheimer's (AD) and Parkinson's disease (PD), respectively. At the other extreme, stable folded helical conformers have been reported to resist self-assembly and amyloid formation. Experimental characterisation of such disparities in aggregation profiles due to subtle differences in peptide stabilities is precluded by the conformational heterogeneity of helical subspace. The diverse physical models used in molecular simulations allow sampling distinct regions of the phase space and are extensive in capturing the ensemble of rich helical subspace. Robust and powerful computational predictive methods utilizing network theory and free energy mapping can model the origin of helical population shifts in amyloidogenic peptides, which highlight their inherent aggregability. In this chapter, we discuss computational models, methods, design rules, and strategies to identify the driving force behind helical self-assembly and the molecular origin of aggregation resistance in helical intermediates of Aβ42 and αS. By extensive multiscale mapping of intrapeptide interactions, we show that the computational models can capture features that are otherwise imperceptible to experiments. Our models predict that targeting terminal residues may allow modulation and control of initial pathogenic aggregability of amyloidogenic peptides.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Central hydrophobic domain; Charged terminal groups; Cross-correlation network analyses; Helical intermediates; Intrinsically disordered proteins; Molecular dynamics simulations; Neurodegenerative disease; Peptide self-assembly; Predictive molecular design

Mesh:

Substances:

Year:  2022        PMID: 35167084     DOI: 10.1007/978-1-0716-1546-1_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  136 in total

1.  The role of NAC in amyloidogenesis in Alzheimer's disease.

Authors:  M Hashimoto; T Takenouchi; M Mallory; E Masliah; A Takeda
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

2.  Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations.

Authors:  V N Uversky; H J Lee; J Li; A L Fink; S J Lee
Journal:  J Biol Chem       Date:  2001-11-23       Impact factor: 5.157

Review 3.  The role of alpha-synuclein in Parkinson's disease: insights from animal models.

Authors:  Eleonora Maries; Biplob Dass; Timothy J Collier; Jeffrey H Kordower; Kathy Steece-Collier
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

4.  Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo.

Authors:  Magali Periquet; Tudor Fulga; Liisa Myllykangas; Michael G Schlossmacher; Mel B Feany
Journal:  J Neurosci       Date:  2007-03-21       Impact factor: 6.167

Review 5.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

6.  Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.

Authors:  Yilin Yan; Chunyu Wang
Journal:  J Mol Biol       Date:  2006-09-23       Impact factor: 5.469

Review 7.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 8.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.

Authors:  Christian Haass; Dennis J Selkoe
Journal:  Nat Rev Mol Cell Biol       Date:  2007-02       Impact factor: 94.444

9.  Structure-neurotoxicity relationships of amyloid beta-protein oligomers.

Authors:  Kenjiro Ono; Margaret M Condron; David B Teplow
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

10.  Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation.

Authors:  Ruitian Liu; Chad McAllister; Yuri Lyubchenko; Michael R Sierks
Journal:  J Neurosci Res       Date:  2004-01-15       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.